An in vitro model for the pro-fibrotic effects of retinoids: Mechanisms of action

British Journal of Pharmacology

Volumn 170, Issue 6, 2013, Pages 1177-1189

  Rankin, A C ^a   Hendry, B M ^a   Corcoran, J P ^a   Xu, Q ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

fibroblasts; fibrosis; kidney; MMP; PAI 1; RAR; retinoic acid; retinoids; RXR; TGF

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RETINOIC ACID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; STROMELYSIN;

ANIMAL CELL; ARTICLE; COLLAGENASE 3 GENE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; FIBROGENESIS; GELATINASE A GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; NONHUMAN; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; STROMELYSIN GENE;

FIBROBLASTS; FIBROSIS; KIDNEY; MMP; PAI-1; RAR; RETINOIC ACID; RETINOIDS; RXR; TGF-Β;

ANIMALS; CELL LINE; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN;

EID: 84886781645     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12348     Document Type: Article

References (59)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-324.
2. Beard RL, Duong TT, Teng M, Klein ES, Standevan AM, Chandraratna RA, (2002). Synthesis and biological activity of retinoic acid receptor-α specific amides. Bioorg Med Chem Lett 12: 3145-3148.
3. Benbow U, Brinckerhoff CE, (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15: 519-526.
4. Bernard BA, Bernardon JM, Delescluse C, Martin B, Lenoir MC, Maignan J, et al. (1992). Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem Biophys Res Commun 186: 977-983.
5. Catania JM, Chen G, Parrish AR, (2007). Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: F905-F911.
6. Chambon P, (1996). A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954.
7. Chen M, Goyal S, Cai X, O'Toole EA, Woodley DT, (1997). Modulation of type VII collagen (anchoring fibril) expression by retinoids in human skin cells. Biochim Biophys Acta 1351: 333-340.
8. Cheng S, Lovett DH, (2003). Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162: 1937-1949.
9. Ebisawa M, Umemiya H, Ohta K, Fukasawa H, Kawachi E, Christoffel G, et al. (1999). Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem Pharm Bull (Tokyo) 47: 1778-1786.
10. Eddy AA, (2009). Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 101: 656-664.
11. El Nahas AM, Bello AK, (2005). Chronic kidney disease: the global challenge. Lancet 365: 331-340.
12. Elokdah H, Abou-Gharbia M, Hennan JK, McFarlane G, Mugford CP, Krishnamurthy G, et al. (2004). Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization. J Med Chem 47: 3491-3494.
13. Fisher GJ, Voorhees JJ, (1998). Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce AP-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc 3: 61-68.
14. Griffiths CE, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ, (1993). Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 329: 530-535.
15. Grotendorst GR, Rahmanie H, Duncan MR, (2004). Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18: 469-479.
16. Hellemans K, Grinko I, Rombouts K, Schuppan D, Geerts A, (1999). All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut 45: 134-142.
17. Hellemans K, Verbuyst P, Quartier E, Schuit F, Rombouts K, Chandraratna RA, et al. (2004). Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology 39: 97-108.
18. Hu Q, Noor M, Wong YF, Hylands PJ, Simmonds MS, Xu Q, et al. (2009). In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 24: 3033-3041.
19. Huang Y, Haraguchi M, Lawrence DA, Border WA, Yu L, Noble NA, (2003). A mutant, non-inhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest 112: 379-388.
20. Huang Y, Border WA, Yu L, Zhang J, Lawrence DA, Noble NA, (2008). A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. J Am Soc Nephrol 19: 329-338.
21. Johnson AT, Klein ES, Gillett SJ, Wang L, Song TK, Pino ME, et al. (1995). Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J Med Chem 38: 4764-4767.
22. Kinoshita K, Funauchi M, (2012). Therapeutic effect of retinoic acid in lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi 35: 1-7.
23. Krag S, Danielsen CC, Carmeliet P, Nyengaard J, Wogensen L, (2005). Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-β1-induced kidney disease. Kidney Int 68: 2651-2666.
24. Krupsky M, Fine A, Berk JL, Goldstein RH, (1994). Retinoic acid-induced inhibition of type I collagen gene expression by human lung fibroblasts. Biochim Biophys Acta 1219: 335-341.
25. Lehrke I, Schaier M, Schade K, Morath C, Waldherr R, Ritz E, et al. (2002). Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol 282: F741-F751.
26. Liu X, Lu L, Tao BB, Zhu YC, (2008). All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-β1 and Ang II in rat mesangial cells. Acta Pharmacol Sin 29: 1035-1041.
27. Liu X, Lü L, Tao BB, Zhou AL, Zhu YC, (2011). Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin. Acta Pharmacol Sin 32: 70-78.
28. Liu Y, (2011). Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696.
29. Livak KJ, Schmittgen TD, (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
30. Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD, (2003). All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 124: 1724-1732.
31. Matsuo S, Lopez-Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, et al. (2005). Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 67: 2221-2238.
32. Meisler NT, Parrelli J, Gendimenico GJ, Mezick JA, Cutroneo KR, (1997). All-trans-retinoic acid inhibition of Pro α1(I) collagen gene expression in fetal rat skin fibroblasts: identification of a retinoic acid response element in the Pro α1(I) collagen gene. J Invest Dermatol 108: 476-481.
33. Morath C, Ratzlaff K, Dechow C, Schwenger V, Schaier M, Zeier B, et al. (2009). Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. J Mol Med (Berl) 87: 53-64.
34. Nangaku M, (2004). Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 43: 9-17.
35. Nishida M, Okumura Y, Ozawa S, Shiraishi I, Itoi T, Hamaoka K, (2007). MMP-2 inhibition reduces renal macrophage infiltration with increased fibrosis in UUO. Biochem Biophys Res Commun 354: 133-139.
36. Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, Ikeda Y, et al. (2001). PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596.
37. Ohta A, Uitto J, (1987). Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro α1(I) and pro α1(III) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum 30: 404-411.
38. Okuno M, Moriwaki H, Imai S, Muto Y, Kawada N, Suzuki Y, et al. (1997). Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells. Hepatology 26: 913-921.
39. Pendaries V, Verrecchia F, Michel S, Mauviel A, (2003). Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner. Oncogene 22: 8212-8220.
40. Pignatello MA, Kauffman FC, Levin AA, (1997). Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition. Toxicol Appl Pharmacol 142: 319-327.
41. Pignatello MA, Kauffman FC, Levin AA, (1999). Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors. Toxicol Appl Pharmacol 159: 109-116.
42. Redlich CA, Delisser HM, Elias JA, (1995). Retinoic acid inhibition of transforming growth factor-β-induced collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol 12: 287-295.
43. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. (1986). Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83: 4167-4171.
44. Schaier M, Liebler S, Schade K, Shimizu F, Kawachi H, Grone HJ, et al. (2004). Retinoic acid receptor α and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med (Berl) 82: 116-125.
45. Schwartz E, Cruickshank FA, Mezick JA, Kligman LH, (1991). Topical all-trans retinoic acid stimulates collagen synthesis in vivo. J Invest Dermatol 96: 975-978.
46. Shigematsu T, Tajima S, (1995). Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts. J Dermatol Sci 9: 142-145.
47. Urbach J, Rando RR, (1994). Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. Biochem J 299 (Pt 2): 459-465.
48. Varani J, Mitra RS, Gibbs D, Phan SH, Dixit VM, Mitra R Jr, et al. (1990). All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol 94: 717-723.
49. Vuligonda V, Thacher SM, Chandraratna RA, (2001). Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. J Med Chem 44: 2298-2303.
50. Wang L, Potter JJ, Rennie-Tankersley L, Novitskiy G, Sipes J, Mezey E, (2007). Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta 1772: 66-71.
51. Watanabe A, Kanai H, Arai M, Sekiguchi K, Uchiyama T, Nagai R, et al. (2002). Retinoids induce the PAI-1 gene expression through tyrosine kinase-dependent pathways in vascular smooth muscle cells. J Cardiovasc Pharmacol 39: 503-512.
52. Wen X, Li Y, Hu K, Dai C, Liu Y, (2005). Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol 167: 947-957.
53. Wong YF, Qu S, Kong Q, Zhang XL, Liang XM, Hu Q, et al. (2012). Knowledge-based discovery of anti-fibrotic and pro-fibrotic activities from Chinese materia medica. In:, Kuang X, (ed.). Recent Advances in Theories and Practice of Chinese Medicine. InTech: Rijeka, Online, pp. 337-352.
54. Xu Q, Konta T, Furusu A, Nakayama K, Lucio-Cazana J, Fine LG, et al. (2002). Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem 277: 41693-41700.
55. Xu Q, Lucio-Cazana J, Kitamura M, Ruan X, Fine LG, Norman JT, (2004). Retinoids in nephrology: promises and pitfalls. Kidney Int 66: 2119-2131.
56. Xu Q, Norman JT, Shrivastav S, Lucio-Cazana J, Kopp JB, (2007). In vitro models of TGF-β-induced fibrosis suitable for high-throughput screening of antifibrotic agents. Am J Physiol Renal Physiol 293: F631-F640.
57. Xu Q, Hendry BM, Maden M, Lu H, Wong YF, Rankin AC, et al. (2010). Kidneys of Alb/TGF-β1 transgenic mice are deficient in retinoic acid and exogenous retinoic acid shows dose-dependent toxicity. Nephron Exp Nephrol 114: e127-e132.
58. Yamane A, Tsukamoto N, Saitoh T, Uchiumi H, Handa H, Karasawa M, et al. (2009). Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney. Intern Med 48: 1691-1694.
59. Zhong Y, Wu Y, Liu R, Li Z, Chen Y, Evans T, et al. (2011). Novel retinoic acid receptor α agonists for treatment of kidney disease. PLoS ONE 6: e27945.